The Motley Fool Discussion Boards

Previous Page

Industry Discussions / Biotechnology


Subject:  HJLI Date:  3/4/2021  11:36 AM
Author:  2K10 Number:  25603 of 25642

Hancock Jaffe HJLI is a pre-revenue medical device company planning trials and IDE for venous valve insufficiency. They recently raise $40M in offering in mid-$7's and are now trading below that, with total market cap about $60M

Added to my mid-size position here today.
Copyright 1996-2021 trademark and the "Fool" logo is a trademark of The Motley Fool, Inc. Contact Us